Botanical species · safety record

Jacobaea vulgaris

The EFSA Compendium of Botanicals holds 7 constituent measurements, 3 adverse-effect records and 1 genotoxicity assay for Jacobaea vulgaris. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Jacobaea vulgaris Gaertn.

7Constituent measurements
4Safety records
6Cited sources
0Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Pyrrolizidine alkaloids7

Plant parts

  • Aerial part of plants4
  • Live plants2
  • Pollen-related2
  • Unspecified2

Preparations

  • Solvent extraction5
  • Drying (dehydration)3

Effect types

  • Hepatotoxicity3

Target tissues

  • Liver2
  • Neurologic: central nervous system1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
Pyrrolizidine alkaloidsUnspecifiedSolvent extraction≥ 74.6 Microgram/millilitreLC-MS/MSResolve DOI
Pyrrolizidine alkaloidsUnspecifiedSolvent extraction≤ 1382.9 Microgram/millilitreLC-MS/MSResolve DOI
Pyrrolizidine alkaloidsPollen-relatedSolvent extraction≤ 800 Microgram/gramHPLC with standard detection methodsResolve DOI
Pyrrolizidine alkaloidsPollen-relatedSolvent extraction≥ 100 Microgram/gramHPLC with standard detection methodsResolve DOI
Pyrrolizidine alkaloidsLive plantsSolvent extraction2339 Milligram/kilogramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
Pyrrolizidine alkaloidsAerial part of plants0.18 PercentResolve DOI
Pyrrolizidine alkaloidsAerial part of plants0.135 PercentResolve DOI

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
HepatotoxicityLiverAerial part of plantsDrying (dehydration)Gallus gallus (chicken) (as animal)Short-term toxicityResolve DOI
HepatotoxicityLiverAerial part of plantsDrying (dehydration)Horse (as animal)Short-term toxicityResolve DOI
HepatotoxicityNeurologic: central nervous systemLive plantsDrying (dehydration)Sheep (as animal)Short-term toxicityResolve DOI

Genotoxicity testing

Outcomes of genotoxicity assays as recorded in the source. A negative assay is a result under those test conditions, not a clearance.

OutcomeEndpointTestTested organismMetabolic activationSource
Positivegene mutationbacterial reverse mutation assaySalmonella typhimurium (as organism)Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. HUAN, JY., CHEEKE, PR., LOWRY, RR., NAKAUE, HS., SNYDER, SP., WHANGER, PD. DIETARY PYRROLIZIDINE (SENECIO) ALKALOIDS AND TISSUE DISTRIBUTION OF COPPER AND VITAMIN-A IN BROILER-CHICKENS. TOXICOLOGY LETTERS, 1992, vol. 62, no. 2-3, p. 139-153. DOI
  2. CRAIG, AM., PEARSON, EG., MEYER, C., SCHMITZ, JA. CLINICOPATHOLOGICAL STUDIES OF TANSY RAGWORT TOXICOSIS IN PONIES - SEQUENTIAL SERUM AND HISTOPATHOLOGICAL CHANGES . Journal of equine veterinary science, 1991, vol. 11, no. 5, p. 261-&. DOI
  3. Bovee, Toine F. H., Helsdingen, Richard J. R., Hoogenboom, Ron L. A. P., de Nijs, Monique W. C. M., Liu, Xiaojie., Vrieling, Klaas., Klinkhamer, Peter G. L., Peijnenburg, Ad A. C. M., Mulder, Patrick P. J. Are effects of common ragwort in the Ames test caused by pyrrolizidine alkaloids? . Mutation research-fundamental and molecular mechanisms of mutagenesis, 2015, vol. 778, p. 1-10. DOI
  4. Boppre, Michael., Colegate, Steven M., Edgar, John A., Fischer, Ottmar W. Hepatotoxic pyrrolizidine alkaloids in pollen and drying-related implications for commercial processing of bee pollen. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2008, vol. 56, no. 14, p. 5662-5672. DOI
  5. Hoogenboom, L. A. P., Mulder, P. P. J., Zeilmaker, M. J., van den Top, H. J., Remmelink, G. J., Brandon, E. F. A., Klijnstra, M., Meijer, G. A. L., Schothorst, R., Van Egmond, H. P. Carry-over of pyrrolizidine alkaloids from feed to milk in dairy cows. Food additives and contaminants part a-chemistry analysis control exposure & risk assessment, 2011, vol. 28, no. 3, p. 359-372. DOI
  6. Hooper, P.T. Spongy degeneration in the central nervous system of domestic animals - Part III: Occurrence and pathogenesis -Hepatocerebral disease caused by hyperammonaemia. Acta neuropathologica, 1975, vol. 31, no. 4, p. 343-351. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue